Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Atopic Dermatitis
Related studies linked through entity extraction aliases.
Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE3
Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis
- Status
- COMPLETED
- Phase
- N/A
Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4
- Status
- COMPLETED
- Phase
- PHASE1
Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis
- Status
- WITHDRAWN
- Phase
- PHASE2
BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients with Atopic Dermatitis
- Status
- RECRUITING
- Phase
- N/A
A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD
- Status
- TERMINATED
- Phase
- PHASE4
Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)
- Status
- COMPLETED
- Phase
- PHASE2
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1
A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE1